• Explore /
  • Poster
  • / Somatic DNA mutations, tumor mutational burden (TMB), and MSI Status: Association with efficacy in patients (pts) with metastatic colorectal cancer (mCRC) of FIRE-3 (AIO KRK-0306).

Somatic DNA mutations, tumor mutational burden (TMB), and MSI Status: Association with efficacy in patients (pts) with metastatic colorectal cancer (mCRC) of FIRE-3 (AIO KRK-0306).

Abstract Poster

Authors

null

Volker Heinemann

Department of Medicine III, University Hospital, LMU Munich, Munich, Germany

Volker Heinemann , Nicole Kraemer , Hannes Buchner , Ludwig Fischer von Weikersthal , Thomas Decker , Alexander Kiani , Ursula Vehling-Kaiser , Salah-Eddin Al-Batran , Tobias Heintges , Christian A. Lerchenmuller , Christoph Kahl , Frank Kullmann , Markus H. Moehler , Werner Scheithauer , Swantje Held , Dominik Paul Modest , Jens Neumann , Andreas Jung , Thomas Kirchner , Sebastian Stintzing

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Epidemiology/Outcomes

Citation

J Clin Oncol 36, 2018 (suppl; abstr 3591)

DOI

10.1200/JCO.2018.36.15_suppl.3591

Abstract #

3591

Poster Bd #

84

Abstract Disclosures

Similar Posters

First Author: Carlotta Antoniotti

First Author: Dalyong Kim

First Author: S. Stintzing

First Author: Takeshi Yamada